Recombinant Human HIST3H2A Protein，His & GST

BPI (Bactericidal/Permeability-Increasing protein) is a crucial component of the innate immune system, primarily found in neutrophils and epithelial cells. It plays a significant role in host defense against bacterial infections by exerting antimicrobial activity and enhancing bacterial phagocytosis. The structure of BPI reveals a unique cationic protein with the ability to bind to lipopolysaccharides found on the surface of Gram-negative bacteria, leading to disruption of their membranes. This interaction not only neutralizes the bacterial threats but also promotes inflammatory responses essential for clearing infections. Research on BPI and its recombinant forms has gained momentum due to its therapeutic potential in treating sepsis, pneumonia, and other infectious diseases, where conventional antibiotics may fail. Advances in molecular biology techniques have enabled the production of recombinant BPI, allowing scientists to study its structure-function relationships and optimize its antimicrobial properties. Additionally, modifications of the BPI protein may enhance its stability and efficacy, paving the way for novel antimicrobial agents that can combat multidrug-resistant pathogens. The ongoing exploration of BPI's mechanisms and its engineered variants aims to harness its full potential for clinical applications, contributing to innovative strategies in infectious disease management.